In the Media: Promising Alzheimer’s Drug Provides Second Chance for Biogen, and a Debated Theory About the Disease

Boston Globe

McLean is part of a new experimental Alzheimer’s disease clinical drug trial.

Media Requests

Journalist or member of the media?
We are available 24/7 for media requests.